RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
VG Life Sciences - Stock

VG Life Sciences EBIT 2024

VG Life Sciences EBIT

-4.14 M USD

Ticker

VGLS

ISIN

US91822T1016

WKN

A1J8VF

In 2024, VG Life Sciences's EBIT was -4.14 M USD, a 6.04% increase from the -3.91 M USD EBIT recorded in the previous year.

The VG Life Sciences EBIT history

YEAREBIT (undefined USD)
2014-
2013-
2012-
2011-
2010-
2009-
2008-
2007-
2006-
2005-
2004-
2003-
2002-
2001-
2000-

VG Life Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into VG Life Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by VG Life Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects VG Life Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of VG Life Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into VG Life Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing VG Life Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on VG Life Sciences’s growth potential.

VG Life Sciences Revenue, Profit, and EBIT History

DateVG Life Sciences RevenueVG Life Sciences EBITVG Life Sciences Net Income
20140 undefined-4.14 M undefined-6.19 M undefined
20130 undefined-3.91 M undefined-7.42 M undefined
20120 undefined-2.6 M undefined-6.85 M undefined
20110 undefined-4.07 M undefined-5.42 M undefined
20105,680 undefined-2.66 M undefined-7.24 M undefined
20090 undefined-3.53 M undefined-7.72 M undefined
20080 undefined-3.74 M undefined-3.81 M undefined
20070 undefined-3.22 M undefined-2.73 M undefined
20060 undefined-6.38 M undefined-12.61 M undefined
20050 undefined-4.41 M undefined-5.03 M undefined
20040 undefined-7.65 M undefined-6.95 M undefined
20030 undefined-4.24 M undefined-4.44 M undefined
20020 undefined-1.26 M undefined-1.78 M undefined
20010 undefined-940,000 undefined-1.36 M undefined
2000350,000 undefined-1.84 M undefined-2.19 M undefined

VG Life Sciences stock margins

The VG Life Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of VG Life Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for VG Life Sciences.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the VG Life Sciences's sales revenue. A higher gross margin percentage indicates that the VG Life Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the VG Life Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the VG Life Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the VG Life Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the VG Life Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the VG Life Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

VG Life Sciences Margin History

VG Life Sciences Gross marginVG Life Sciences Profit marginVG Life Sciences EBIT marginVG Life Sciences Profit margin
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %-46,835.21 %-127,468.66 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %
20060 %0 %0 %
20050 %0 %0 %
20040 %0 %0 %
20030 %0 %0 %
20020 %0 %0 %
20010 %0 %0 %
20000 %-525.71 %-625.71 %

VG Life Sciences Aktienanalyse

What does VG Life Sciences do?

VG Life Sciences Inc is a California-based company that specializes in the research, development, and commercialization of new medical technologies and products. The company collaborates closely with researchers, academics, and professionals worldwide to develop and market innovative solutions for the healthcare industry. Its core business is the research and development of drugs based on plant substances and natural products. The company has developed a unique technology platform that allows for the selection of specific target molecules in the human body from thousands of natural compounds. These compounds are further studied and optimized to develop active ingredients for the treatment of various diseases. VG Life Sciences also has its own line of dietary supplements and skincare products based on natural ingredients. These products are available under the brand Vivid GLOW and are sold on online platforms and selected retail stores. The company also focuses on dietary supplements and uses its extensive medical expertise to develop high-quality products based on the latest research. These products are designed to promote overall health and enable a longer and more productive life. Another business area of VG Life Sciences is its laboratory services business. The company offers a wide range of services, from raw material analysis to drug formulation and clinical drug testing. It has significantly expanded its capabilities and now has a modern analysis and research laboratory equipped with the latest technological instruments and devices. The company also provides training and consulting services to support customers in the development and marketing of new medical products. VG Life Sciences is committed to ensuring high quality and scientific excellence in all business areas. To achieve this, the company has assembled a team of experienced researchers and scientists and collaborates with various academic and industry partners. It places great emphasis on compliance with standards and regulations and works closely with relevant authorities to ensure that its products and services meet the highest standards. Overall, VG Life Sciences Inc is an innovative and emerging company focused on the development and commercialization of new medical technologies and products. The company has a unique technology platform, a wide range of products and services, and a dedicated team of professionals. It strives to ensure high quality and scientific excellence in all business areas and to become a key player in the healthcare industry. VG Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing VG Life Sciences's EBIT

VG Life Sciences's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of VG Life Sciences's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

VG Life Sciences's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in VG Life Sciences’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about VG Life Sciences Stock

How much did VG Life Sciences achieve in EBIT for the current year?

In the current year, VG Life Sciences has achieved an EBIT of -4.14 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company VG Life Sciences.

How has the EBIT of VG Life Sciences developed in recent years?

The EBIT of VG Life Sciences has increased by 6.039% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company VG Life Sciences?

The EBIT of VG Life Sciences is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does VG Life Sciences pay?

Over the past 12 months, VG Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, VG Life Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of VG Life Sciences?

The current dividend yield of VG Life Sciences is .

When does VG Life Sciences pay dividends?

VG Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of VG Life Sciences?

VG Life Sciences paid dividends every year for the past 0 years.

What is the dividend of VG Life Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is VG Life Sciences located?

VG Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von VG Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of VG Life Sciences from 6/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.

When did VG Life Sciences pay the last dividend?

The last dividend was paid out on 6/29/2024.

What was the dividend of VG Life Sciences in the year 2023?

In the year 2023, VG Life Sciences distributed 0 USD as dividends.

In which currency does VG Life Sciences pay out the dividend?

The dividends of VG Life Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von VG Life Sciences

Our stock analysis for VG Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of VG Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.